China Shineway Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
China Shineway Pharmaceutical Group has a total shareholder equity of CN¥7.3B and total debt of CN¥330.0M, which brings its debt-to-equity ratio to 4.5%. Its total assets and total liabilities are CN¥9.9B and CN¥2.5B respectively. China Shineway Pharmaceutical Group's EBIT is CN¥944.7M making its interest coverage ratio -5.7. It has cash and short-term investments of CN¥6.2B.
Key information
4.5%
Debt to equity ratio
CN¥330.00m
Debt
| Interest coverage ratio | -5.7x |
| Cash | CN¥6.23b |
| Equity | CN¥7.34b |
| Total liabilities | CN¥2.55b |
| Total assets | CN¥9.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: C1S's short term assets (CN¥8.5B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: C1S's short term assets (CN¥8.5B) exceed its long term liabilities (CN¥113.0M).
Debt to Equity History and Analysis
Debt Level: C1S has more cash than its total debt.
Reducing Debt: C1S's debt to equity ratio has increased from 0% to 4.5% over the past 5 years.
Debt Coverage: C1S's debt is well covered by operating cash flow (356.2%).
Interest Coverage: C1S earns more interest than it pays, so coverage of interest payments is not a concern.